This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Knowledge Base Remove Manufacturing Remove Presentation Related Topics
Government Security Compliance Marketing Digital transformation Risk Privacy Sales Artificial Intelligence Analytics More Related Topics >
article thumbnail

EU Commission Issues Draft AI Regulation

Data Matters

APRIL 23, 2021

AI systems that are considered to present an “unacceptable” level of risk are banned from the EU, and “high-risk” systems are subject to strict requirements. AI systems which are considered to present a lower risk level are subject to transparency requirements or are not regulated at all.

Artificial Intelligence 74
Artificial Intelligence GDPR Risk Marketing 74
article thumbnail

Leveraging generative AI on AWS to transform life sciences

IBM Big Data Hub

JULY 19, 2023

Life sciences industry has—for decades now—moved from the traditional discovery-based drug development to target market-based drug development paradigm. Yet, it is burdened by long R&D cycles and labor-intensive clinical, manufacturing and compliancy regimens.

Marketing 65
Marketing Manufacturing Analytics Compliance 65
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 55,000+ Insiders by signing up for our newsletter

About
Webinars
Awards
About
Editions
Webinars
Awards
Editions
Topics
Twitter
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024